期刊文献+

分泌mRANTES趋化因子的小鼠肝癌细胞的建立及其体内致瘤性的初步研究 被引量:4

Establishment of A Mouse Hepatocellular Carcinoma Cell Line That Produces mRANTES Chemokines and the Tumorigenecity of mRANTES Transfected Hepal-6
下载PDF
导出
摘要 目的:建立分泌mRANTES的小鼠肝癌细胞,并观察其体内致瘤性。方法:mRANTEScDNA被克隆入pBabepuro逆转录病毒载体,构建的重组逆转录病毒载体pBabepuromRANTES转染包装细胞,嘌呤酶素抗性细胞培养上清感染小鼠肝癌细胞系Hepa1-6,免疫组化检测Hepa1-6、Hepa1-6mRANTES的mRANTES蛋白的表达。绘制Hepa1-6mRANTES与Hepa1-6的生长曲线观察细胞的生长。琼脂糖凝胶打孔法体外观察Hepa1-6mRANTES分泌蛋白对小鼠脾细胞的趋化作用。观察Hepa1-6mRANTES体内致瘤性。结果:构建了重组逆转录病毒载体pBabepuromRANTES,Hepa1-6不表达mRANTES,Hepa1-6mRANTES表达mRANTES蛋白。Hepa1-6mRANTES与Hepa1-6的生长曲线基本一样。Hepa1-6mRANTES分泌了对小鼠脾细胞有趋化作用的分子。Hepa1-6mRANTES体内致瘤性降低。结论:Hepa1-6mRANTES能产生mRANTES,mRANTES不改变细胞体外生长状况,Hepa1-6mRANTES产生的mRANTES有趋化活性,mRANTES能使Hepa1-6mRANTES致瘤性降低。 Objective:To establish a mouse hepatocellular carcinoma that can produce mRANTES and to evaluate the possibility of cancer gene therapy by mMIP -1.Methods:mRANTES cDNA was cloned into retrovirus vector pBabe puro and pBabe puro mRANTES was constructed,then pBabe puro -mRANTES was used to transfect packaging cells.The anti -puromycin cells were proliferated and the supernatant was used to infect hepal-6.The anti-puromycin clone(hepal-6mRANTES)and hepal-6were analysed for the expression of mMIP-1-protein by immunohistochemistry.The growth curves of hepal-6and hepal-6mRANTES were drawn.The chemotaxis of mRANTES produced by hepal-6mRANTES to mouse spleen cells was observed on agarose gel.C57B/L mouse was inoculated with the tumor cells and the tumorigenecity was studied.Results:Recombinant retrovirus vector pBabe puro mRANTES with mRANTES cDNA was constructed.Hepal-6could not produce mRANTES protein,while hepal-6mRANTES could produce mRANTES protein.The growth curves of hepal -6and hepal -6 mRANTES showed no difference.The chemotaxis of mRANTES produced by hepal-6mRANTES to mouse spleen cells was observed.The tumorigenecity was reduced.Conclusion:In this study,a mouse hepatocellular carcinoma hepal-6mRANTES is established,and it show that mRANTES can affect the tumorigenecity of hepal-6.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2002年第1期53-57,共5页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金资助(项目编号:39770404 39730440 39900070)
关键词 趋化因子 RNATES 肝癌 基因治疗 动物实验 免疫疗法 Chemokines mRANTES Immunogenetherapy Hepatocellular carcinoma
  • 相关文献

参考文献6

  • 1LusterAD,LederP.IP-10,aCXCchemokineelicitsapo-tentthymus-dependentantitumorresponseinvivo[].The Journal of Experimental Medicine.1993
  • 2CookDN,SmithiesO,StrieterRM,etal.CD8+Tcellsareabiologicallyrelevantsourceofmacrophageinflammatoryprotein-1alphainvivo[].JImmunol.1999
  • 3DasAM,AjueborMN,FlowerRJ,etal.ContrastingrolesforRANTESandmacrophageinflammatoryprotein-1alpha(MIP-1alpha)inamurinemodelofallergicperitonitis[].Clinical and Experimental Immunology.1999
  • 4NakashimaE,MukaidaN,KubotaYetal.HumanMCAFgenetransferenhancesthemetastaticcapacityofamousecachecticadenocarcinomacelllineinvitro[].PharmaceuticalRes.1995
  • 5HiroseK,HakozakiM,NyunoyaYetal.Chemokinegenetransfectionintotumorcellsreducedtumorigenicityinnudemiceinassociationwithneutrophilinfiltration[].British Journal of Cancer.1995
  • 6CrismanJM,ElderPJ,WilkieNM,etal.IdentificationofaminoacidsinvolvedinthebindingofhMIP-1alphatoCC-CKR1,aMIP-1alphareceptorfoundonneutrophils[].Molecular and Cellular Biochemistry.1999

同被引文献23

  • 1张银刚,郭雄,周京军,鱼兵,刘兵.携EGFP基因的逆转录病毒包装细胞的分选和滴度测定[J].第一军医大学学报,2005,25(1):30-32. 被引量:5
  • 2张盈帆,江华,林子豪,蔡在龙,吴包金.聚集蛋白基因在原代培养成肌细胞中的表达[J].中华实验外科杂志,2005,22(12):1562-1564. 被引量:7
  • 3马国秀,梁再赋,张士发,许静,赵丽萍,王良明.多发性肌炎和皮肌炎患者PBMC表面CD43分子的表达[J].中国麻风皮肤病杂志,2006,22(4):274-276. 被引量:4
  • 4王振发,王烈,卫立辛.趋化因子和B7分子联合应用抗肿瘤的研究进展[J].中国肿瘤生物治疗杂志,2007,14(1):94-96. 被引量:4
  • 5Kaufman HL, Deraffele G, Mitcham J, et al. Targeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanoma.J Clin Invest, 2005, 115 (7): 1903-1912.
  • 6Ben - Baruch A. The multifaceted roles of chemokines in malignancy. Cancer Metastasis Rev, 2006 Oct 3 ; [ Epub ahead of print].
  • 7Curiel TJ, Coukos G, Zou L, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med, 2004, 10 (9): 942- 949.
  • 8Delman KA, Zager JS, Bennett J J, et al. Efficacy of multiagent herpes simplex virus amplicon - mediated immunotherapy as adju- vant treatment for experimental hepatic cancer. Ann Surg, 2002, 236 (3): 337-343.
  • 9He YF, Zhang GM, Wang XH, et al.Blockiog Programmed Death - 1 Ligend - PD - 1 Interactions by local gene therapy results in enhancement of antitumor effect of secondary lymphoid tissue chemokine.J Immunol, 2004, 173 (8) : 4919 - 4928.
  • 10Somia N. Gene transfer by retroviral vectors: An overview. Methods Mol Biol, 2004, 246:463-90.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部